Database parameters

The consensus from the euLITT meeting in September 2024 was that local prospective databases should include the following parameters (at a minimum)

 

Tumor

Age, Gender, ID-number, Operation date

  • Location (frontal, temporal, parietal, occipital, insula, brainstem, posterior fossa, central)
  • Tumor indication: Newly-diagnosed glioblastoma / Recurrent glioblastoma / Glioma grade 1 / Glioma grade 2 / Glioma grade 3 / Glioma grade 4 (IDH-mutant) Metastasis / Radiation necrosis / Meningioma / Pediatric brain tumor / Cavernoma / Hemangioma / Other (Text)
  • Brain tumor diagnosis date (date of biopsy)
  • Initial biopsy result (classification and mutations)
  • Biopsy in same session as LITT: Yes (Text) / No
  • Complications: Yes (Text) / No
  • Recurrence 4-6 weeks post-LITT: Yes / No
  • Recurrence 3 months post-LITT: Yes / No
  • Recurrence 6 months post-LITT: Yes / No
  • Date of recurrence on MRI
  • Date of death

 

Epilepsy

  • Age, Gender, ID-number, Operation date
  • Location (frontal, temporal,parietal, occipital, insula, central)
  • Epilepsy indication: Mesial temporal epilepsy MRI positive / Mesial temporal epilepsy MRI negative / Hypothalamic hamartoma / Dysplasia / Heterotopia / Extratemporal MRI negative / Glioneural tumors (e.g. gangliogliomas, DNET) / Hemangioma / Cavanoma / Corpus callosotomy / Tuberous sclerosis / Other (Text)
  • Complications: Yes (Text) / No
  • Neurological deficits at 12 months:Yes (Text) / No
  • Engel and ILAE outcome at 12 months
  • Engel and ILAE outcome at 24 months